An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Detaylı Bibliyografya
Asıl Yazarlar:	Campa, D, Kaaks, R, Le Marchand, L, Haiman, C, Travis, R, Ziegler, R, Hunter, D, Lindstroem, S, Canzian, F
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2012

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Tsilidis, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Lindström, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Ahn, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Setiawan, V, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Cox, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
Yazar:: Lund Eiliv, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
Yazar:: Campa, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Yazar:: Campa, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Yazar:: Mondul, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
Yazar:: Barrdahl, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
Yazar:: Joshi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
Yazar:: Machiela, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Yazar:: Chen, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Yazar:: Lindstrom, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Yazar:: Shui, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Yazar:: Lindström, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Yazar:: Travis, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
Yazar:: Shui, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Yazar:: Sara Lindstrom, ve diğerleri
Baskı/Yayın Bilgisi: (2011-02-01)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
Yazar:: Mathew, Angelin Tresa, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
Yazar:: Mathew, Angelin T., ve diğerleri
Baskı/Yayın Bilgisi: (2022)

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Yazar:: Agarwal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Yazar:: Tsilidis, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
Yazar:: Milne, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
Yazar:: Muna Ahmed Eltayeb, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
Yazar:: Cox, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
Yazar:: Koutros, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
Yazar:: Anna D. Cirac, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
Yazar:: Yang, X, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women
Yazar:: Carolyn Nickson, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
Yazar:: Jirong Long, ve diğerleri
Baskı/Yayın Bilgisi: (2010-06-01)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
Yazar:: Schumacher, F, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The role of osteoprotegerin in breast and prostate cancer
Yazar:: Holen, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The impact of transcription on metabolism in prostate and breast cancers
Yazar:: Poulose, N, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
Yazar:: Emma H. Allott, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

The Prostate Cancer Research Consortium Bioresource (Ireland)
Yazar:: Antony Wekesa, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

Nutrition and breast cancer.
Yazar:: Key, T, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Yazar:: Foluso O. Ademuyiwa, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Benzer Materyaller

Benzer Materyaller